XML 118 R103.htm IDEA: XBRL DOCUMENT v3.3.1.900
Guarantor Financial Information Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jan. 02, 2016
Oct. 03, 2015
Jul. 04, 2015
Apr. 04, 2015
Jan. 03, 2015
Sep. 27, 2014
Jun. 28, 2014
Mar. 29, 2014
Jan. 02, 2016
Jan. 03, 2015
Dec. 28, 2013
Net income $ 85,875 $ (7,357) $ 4,937 $ 1,824 $ 68,788 $ 15,954 $ 34,575 $ (51,006) $ 85,279 $ 68,311 $ 108,967
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 0 0 0
Other operating cash flows                 336,069 206,861 101,754
Net cash provided by operating activities                 421,348 275,172 210,721
Cash flows from investing activities:                      
Capital expenditures [1]                 (229,848) (228,918) (118,307)
Acquisitions, net of cash acquired                 (377) (2,094,400) (734,075)
Investment in unconsolidated subsidiary                 0 0 (44,959)
Note receivable from affiliates                 0 0 0
Gross proceeds from sale of property, plant and equipment and other assets                 3,840 9,262 2,358
Proceeds from insurance settlement                 561 1,550 1,981
Payments related to routes and other intangibles                 (3,845) (11,288) (2,423)
Net cash used in investing activities                 (229,669) (2,323,794) (895,425)
Cash flows from financing activities:                      
Proceeds from long-term debt                 590,745 1,842,184 344,704
Payments on long-term debt                 (609,255) (333,762) (580)
Borrowings from revolving credit facility                 78,244 170,143 293,235
Payments on revolving credit facility                 (166,755) (351,589) (5,000)
Net cash overdraft financing                 (1,261) 4,077 0
Borrowings from affiliates                     0
Deferred loan costs                 (17,310) (45,223) (13,320)
Issuance of common stock                 171 416 840,558
Repurchase of treasury stock                 (5,912) 0 0
Contributions from parent                 0 0 0
Minimum withholding taxes paid on stock awards                 (4,874) (10,026) (3,289)
Excess tax benefit/(expense) from stock-based compensation                 (389) 2,420 1,138
Addition/(deductions) of noncontrolling interest                 (87) 1,201 0
Distributions to noncontrolling interests                 (3,295) (4,272) 0
Net cash provided/(used) in financing activities                 (139,978) 1,275,569 1,457,446
Effect of exchange rate changes on cash flows                 (3,601) 10,980 (5,134)
Net increase/(decrease) in cash and cash equivalents                 48,100 (762,073) 767,608
Cash and cash equivalents at beginning of year       108,784       870,857 108,784 870,857 103,249
Cash and cash equivalents at end of year 156,884       108,784       156,884 108,784 870,857
Issuer [Member]                      
Net income                 85,279 68,311 108,967
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 (198,371) (223,790) (105,178)
Other operating cash flows                 250,986 226,120 135,315
Net cash provided by operating activities                 137,894 70,641 139,104
Cash flows from investing activities:                      
Capital expenditures                 (46,574) (39,248) (45,173)
Acquisitions, net of cash acquired                 0 0 0
Investment in unconsolidated subsidiary                 (20) (1,483,007) (600,537)
Note receivable from affiliates                 0 0 0
Gross proceeds from sale of property, plant and equipment and other assets                 1,035 1,522 1,329
Proceeds from insurance settlement                 71 1,350 1,531
Payments related to routes and other intangibles                 0 (9,640) (2,423)
Net cash used in investing activities                 (45,488) (1,529,023) (645,273)
Cash flows from financing activities:                      
Proceeds from long-term debt                 0 1,100,000 200,000
Payments on long-term debt                 (16,111) (264,500) 0
Borrowings from revolving credit facility                 25,000 122,445 245,000
Payments on revolving credit facility                 (90,000) (297,445) (5,000)
Net cash overdraft financing                 0 0  
Borrowings from affiliates                     0
Deferred loan costs                 (7,295) (41,748) (11,916)
Issuance of common stock                 171 416 840,558
Repurchase of treasury stock                 (5,912)    
Contributions from parent                 0 0 0
Minimum withholding taxes paid on stock awards                 (4,874) (10,026) (3,289)
Excess tax benefit/(expense) from stock-based compensation                 (389) 2,420 1,138
Addition/(deductions) of noncontrolling interest                 0 0  
Distributions to noncontrolling interests                 0 0  
Net cash provided/(used) in financing activities                 (99,410) 611,562 1,266,491
Effect of exchange rate changes on cash flows                 0 0 0
Net increase/(decrease) in cash and cash equivalents                 (7,004) (846,820) 760,322
Cash and cash equivalents at beginning of year       10,447       857,267 10,447 857,267 96,945
Cash and cash equivalents at end of year 3,443       10,447       3,443 10,447 857,267
Guarantors [Member]                      
Net income                 101,828 155,250 107,317
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 0 0 0
Other operating cash flows                 (53,098) (34,238) (39,459)
Net cash provided by operating activities                 48,730 121,012 67,858
Cash flows from investing activities:                      
Capital expenditures                 (91,702) (84,299) (68,716)
Acquisitions, net of cash acquired                 0 (19,394) (121,440)
Investment in unconsolidated subsidiary                 (45,103) (1,442,788) (63,115)
Note receivable from affiliates                 76,019 (204,074) (370,996)
Gross proceeds from sale of property, plant and equipment and other assets                 1,154 5,155 1,029
Proceeds from insurance settlement                 490 200 450
Payments related to routes and other intangibles                 0 0 0
Net cash used in investing activities                 (59,142) (1,745,200) (622,788)
Cash flows from financing activities:                      
Proceeds from long-term debt                 0 0 0
Payments on long-term debt                 (55) (87) (82)
Borrowings from revolving credit facility                 0 0 0
Payments on revolving credit facility                 0 0 0
Net cash overdraft financing                 0 0  
Borrowings from affiliates                     0
Deferred loan costs                 0 0 0
Issuance of common stock                 0 0 0
Repurchase of treasury stock                 0    
Contributions from parent                 0 1,632,618 555,552
Minimum withholding taxes paid on stock awards                 0 0 0
Excess tax benefit/(expense) from stock-based compensation                 0 0 0
Addition/(deductions) of noncontrolling interest                 0 0  
Distributions to noncontrolling interests                 0 0  
Net cash provided/(used) in financing activities                 (55) 1,632,531 555,470
Effect of exchange rate changes on cash flows                 0 0 0
Net increase/(decrease) in cash and cash equivalents                 (10,467) 8,343 540
Cash and cash equivalents at beginning of year       14,460       6,117 14,460 6,117 5,577
Cash and cash equivalents at end of year 3,993       14,460       3,993 14,460 6,117
Non-guarantors [Member]                      
Net income                 96,543 68,540 (2,139)
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 0 0 0
Other operating cash flows                 138,181 14,979 5,898
Net cash provided by operating activities                 234,724 83,519 3,759
Cash flows from investing activities:                      
Capital expenditures                 (91,572) (105,371) (4,418)
Acquisitions, net of cash acquired                 (377) (2,075,006) (612,635)
Investment in unconsolidated subsidiary                 29,541 (440,619) (44,959)
Note receivable from affiliates                 (76,019) 204,074 0
Gross proceeds from sale of property, plant and equipment and other assets                 1,651 2,585 0
Proceeds from insurance settlement                 0 0 0
Payments related to routes and other intangibles                 (3,845) (1,648) 0
Net cash used in investing activities                 (140,621) (2,415,985) (662,012)
Cash flows from financing activities:                      
Proceeds from long-term debt                 590,745 742,184 144,704
Payments on long-term debt                 (593,089) (69,175) (498)
Borrowings from revolving credit facility                 53,244 47,698 48,235
Payments on revolving credit facility                 (76,755) (54,144) 0
Net cash overdraft financing                 (1,261) 4,077  
Borrowings from affiliates                     370,996
Deferred loan costs                 (10,015) (3,475) (1,404)
Issuance of common stock                 0 0 0
Repurchase of treasury stock                 0    
Contributions from parent                 15,582 1,733,796 108,100
Minimum withholding taxes paid on stock awards                 0 0 0
Excess tax benefit/(expense) from stock-based compensation                 0 0 0
Addition/(deductions) of noncontrolling interest                 (87) 1,201  
Distributions to noncontrolling interests                 (3,295) (4,272)  
Net cash provided/(used) in financing activities                 (24,931) 2,397,890 670,133
Effect of exchange rate changes on cash flows                 (3,601) 10,980 (5,134)
Net increase/(decrease) in cash and cash equivalents                 65,571 76,404 6,746
Cash and cash equivalents at beginning of year       83,877       7,473 83,877 7,473 727
Cash and cash equivalents at end of year 149,448       83,877       149,448 83,877 7,473
Eliminations [Member]                      
Net income                 (198,371) (223,790) (105,178)
Cash flows from operating activities:                      
Earnings in investments in subsidiaries                 198,371 223,790 105,178
Other operating cash flows                 0 0 0
Net cash provided by operating activities                 0 0 0
Cash flows from investing activities:                      
Capital expenditures                 0 0 0
Acquisitions, net of cash acquired                 0 0 0
Investment in unconsolidated subsidiary                 15,582 3,366,414 663,652
Note receivable from affiliates                 0 0 370,996
Gross proceeds from sale of property, plant and equipment and other assets                 0 0 0
Proceeds from insurance settlement                 0 0 0
Payments related to routes and other intangibles                 0 0 0
Net cash used in investing activities                 15,582 3,366,414 1,034,648
Cash flows from financing activities:                      
Proceeds from long-term debt                 0 0 0
Payments on long-term debt                 0 0 0
Borrowings from revolving credit facility                 0 0 0
Payments on revolving credit facility                 0 0 0
Net cash overdraft financing                 0 0  
Borrowings from affiliates                     (370,996)
Deferred loan costs                 0 0 0
Issuance of common stock                 0 0 0
Repurchase of treasury stock                 0    
Contributions from parent                 (15,582) (3,366,414) (663,652)
Minimum withholding taxes paid on stock awards                 0 0 0
Excess tax benefit/(expense) from stock-based compensation                 0 0 0
Addition/(deductions) of noncontrolling interest                 0 0  
Distributions to noncontrolling interests                 0 0  
Net cash provided/(used) in financing activities                 (15,582) (3,366,414) (1,034,648)
Effect of exchange rate changes on cash flows                 0 0 0
Net increase/(decrease) in cash and cash equivalents                 0 0 0
Cash and cash equivalents at beginning of year       $ 0       $ 0 0 0 0
Cash and cash equivalents at end of year $ 0       $ 0       $ 0 $ 0 $ 0
[1] Excludes the capital assets acquired in an immaterial acquisition in fiscal 2015, the VION Acquisition and Custom Blenders acquisition in fiscal 2014 of approximately $984.2 million, the Terra Transaction and the Rothsay Acquisition in fiscal 2013 of approximately $167.0 million